Morgan Stanley analyst Brian Harbour upgrades Portillos (NASDAQ:PTLO) from Equal-Weight to Overweight.
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $45
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $40 to $45.